skip to main content
Centre for Health Economics and Policy Analysis


PMPRB policy change topic of next CHEPA seminar

16 Oct 2017

Dr. Mitchell Levine, a Governor-in-Council appointment as the Vice-Chair of the Patented Medicine Prices Review Board of Canada (PMPRB) and the board’s Acting Chair and CEO, will present the next CHEPA seminar, PMPRB: A time for policy change?, on Weds Oct. 18.

The PMPRB was conceived in 1987 as Bill C-22’s “consumer protection pillar” against excessive drug prices. Canada, like many countries, faces rising health care costs as payers struggle to reconcile finite budgets with patient access to promising new health technologies. Making prescription drugs more affordable is a shared Federal-Provincial-Territorial priority.

The PMPRB’s authority to regulate patented drug prices reposes on three legal instruments, the Patent Act, the Patented Medicines Regulations, and the Compendium of Policies, Guidelines and Procedures (“Guidelines”). The release of a discussion paper on the modernizing the guidelines, and the announcement of pending changes to PMPRB regulations indicate an active process for policy change in this jurisdiction.

In addition to his work as Vice-Chair of the board, Levine also serves as an advisor to federal and provincial governments on issues relating to drug safety, efficacy and pharmaco-economics.

He is a Professor in McMaster’s Department of Health Research Methods, Evidence and Impact and in the Department of Medicine, Division of Clinical Pharmacology. He is also the Assistant for the Heath Research Dean Methodology program. He is a member of the Program for Assessment of Technology in Health (P.A.T.H) and the Centre for Evaluation of Medicines (both affiliated with St. Joseph’s Healthcare Hamilton and McMaster University). He is a practicing consultant physician in the fields of Internal Medicine and Clinical Pharmacology at St. Joseph's Healthcare Hamilton.

He received his medical degree from the University of Calgary, which was followed by postgraduate medical training in Internal Medicine and in Clinical Pharmacology at the University of Toronto. He received an MSc in Clinical Epidemiology from McMaster University.

His academic activities include assessing prescription drug use in the community and developing methods to obtain maximum value from drug therapy resources. He is the Editor for both the Canadian Journal of General Internal Medicine and the Journal of Population Therapeutics and Clinical Pharmacology, and is an Associate Editor for ACP Journal Club.

The seminar takes place on Weds Oct. 18 in CRL-B119, from 12:30 to 1:30 p.m. All are welcome to attend. If you are unable to attend in person you are welcome to participate remotely online, using WebEx. Copy and paste the link below to join the meeting:

The case-sensitive password is MW6sCtgJ
Please send questions, comments or suggestions to the Webmaster ( ).
Please review our Copyright Disclaimer policy

Interactive Marketing | Cubicle Fugitive